<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:svg="http://www.w3.org/2000/svg" lang="en" xml:lang="en">
<head>
<title>Chapter 15 Assessment in Chapter 15 The Genetic Code and Translation</title>
<meta charset="utf-8"/>
<meta content="final" name="process"/>
<meta content="3.1" name="schema"/>
<link href="../styles/pie_9781319216801.css" rel="stylesheet" type="text/css"/>
<meta content="urn:uuid:1df703a4-880e-4fb4-a16f-bd0ab0744194" name="Adept.expected.resource"/>
</head>
<body class="bodymatter" epub:type="bodymatter">
<section class="end-of-section" id="ben_9781319297145_AParE1VzSf" title="WORKED PROBLEMS">
<header id="ben_9781319297145_xYkQxagsFz"><h2 class="title" epub:type="title" id="ben_9781319297145_xa7UjUbQ8B">Chapter 15 Assessment</h2></header>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_GILue1VF6K">
<header id="ben_9781319297145_bSFtmK8CWQ"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_YIyqKZhPIj">Comprehension Questions</h3></header>
<section class="subsect1" id="ben_9781319297145_pF1Q9pMqc5">
<header id="ben_9781319297145_PbVvYe5d89"><h4 class="level1" id="ben_9781319297145_m9tSdyJVkO">Section 15.1</h4></header>
<ol class="numbered-list" id="ben_9781319297145_kFxmU6roUx">
<li class="question noindent" epub:type="question" id="ben_9781319297145_xhZrAnmD15">What is the one gene, one enzyme hypothesis? Why was this hypothesis an important advance in our understanding of genetics?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_uEh9xQLJda">
<header id="ben_9781319297145_frGXkJd8ar"><h4 class="level1" id="ben_9781319297145_ngTbbEJCRq">Section 15.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_MGtOUgXYpE" start="2">
<li class="question noindent" epub:type="question" id="ben_9781319297145_ViLjRGbCGr">What different methods were used to help break the genetic code? What did each method reveal, and what were the advantages and disadvantages of each one?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_JN2aiOkGxs">What are isoaccepting tRNAs?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_GIrnY9yrDE">What is the significance of the fact that many synonymous codons differ only in the third nucleotide position?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_lPj66F49T4">Define the following terms as they apply to the genetic code:
<ol class="ol-alpha-lc" id="ben_9781319297145_2GwZgydT5F">
<li class="question noindent" epub:type="question" id="ben_9781319297145_vR0wxNqYUi">Reading frame</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_HjzBFu4wDd">Overlapping code</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_kLn20AL1G0">Nonoverlapping code</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_wfVxJ4om9T">Initiation codon</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_OFObXiHvUm">Termination codon</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_4gPsVj4x6x">Sense codon</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_BYSul2XBsb">Nonsense codon</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_FhXkYewLFh">Universal code</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_sQHUwPZ3cZ">Nonuniversal codons</li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_AqPbRqnTpu">How is the reading frame of a nucleotide sequence set?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_UGCigmS53g">
<header id="ben_9781319297145_nSspElQxy5"><h4 class="level1" id="ben_9781319297145_CuZ2bP2l28">Section 15.3</h4></header>
<ol class="numbered-list" id="ben_9781319297145_rdWKWmNZdJ" start="7">
<li class="question noindent" epub:type="question" id="ben_9781319297145_wuzvchy066">How are tRNAs linked to their corresponding amino acids?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_9pVTr0g9G1">What role do the initiation factors play in protein synthesis?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_U7CvpJwh3S">How does the process of initiation differ in bacterial and eukaryotic cells?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_7rTo9Iv4qt">Give the elongation factors used in bacterial translation, and explain the role played by each factor in translation.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_QCOvzBRCSv">What events bring about the termination of translation?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_FdSMpZrEF2">Compare and contrast the process of protein synthesis in bacterial and eukaryotic cells, giving similarities and differences in the process of translation in these two types of cells.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_lRwOzi56kj">
<header id="ben_9781319297145_5MjMLSSGwo"><h4 class="level1" id="ben_9781319297145_stY7Nt8HzJ">Section 15.4</h4></header>
<ol class="numbered-list" id="ben_9781319297145_RqYYIyFAwQ" start="13">
<li class="question noindent" epub:type="question" id="ben_9781319297145_5lR90suGB7">How do prokaryotic cells overcome the problem of a stalled ribosome on an mRNA that has no termination codon? How do eukaryotic cells solve this problem?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_GkIRartZBF">What are some types of posttranslational modification of proteins?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_KY6a1eoUEM">Explain how some antibiotics work by affecting the process of protein synthesis.</li>
</ol>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_MSKfSGboGU">
<header id="ben_9781319297145_y2G2C6iGoR"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_FfzrGHOhHl"><span aria-label="463" epub:type="pagebreak" id="page463" role="doc-pagebreak" title="463"/>Application questions and problems</h3></header>
<section class="subsect1" id="ben_9781319297145_E9CoUoa2z3">
<header id="ben_9781319297145_PESgGiSE8u"><h4 class="level1" id="ben_9781319297145_wh6mH7SS9K">Section 15.1</h4></header>
<ol class="numbered-list" id="ben_9781319297145_sugUPZ0RHO" start="16">
<li class="question noindent" epub:type="question" id="ben_9781319297145_wPHUBAXSkX"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_YCGljjll3W" id="ben_9781319297145_pJINpXDPhn">*</a>Sydney Brenner isolated <i class="semantic-i" id="ben_9781319297145_5RtobUYy0h">Salmonella typhimurium</i> mutants that were implicated in the biosynthesis of tryptophan and would not grow on a minimal medium. When these bacterial mutants were tested on a minimal medium to which one of four compounds (indole glycerol phosphate, indole, anthranilic acid, and tryptophan) had been added, the growth responses shown in the following table were obtained.
<table class="table sectioned c3 main-flow" id="ben_9781319297145_SAwUyg9LlH">
<tr id="ben_9781319297145_KA7LUim35s">
<th class="left" id="ben_9781319297145_VKaUieWTjg">Mutant</th>
<th class="center" id="ben_9781319297145_bZrDFoMoOI">Minimal medium</th>
<th class="center" id="ben_9781319297145_nr3ad5jh3s">Anthranilic acid</th>
<th class="center" id="ben_9781319297145_8u28VH0ccT">Indole glycerol phosphate</th>
<th class="center" id="ben_9781319297145_UQ2E5kI4G5">Indole</th>
<th class="center" id="ben_9781319297145_5xOWE4hAhM">Tryptophan</th>
</tr>
<tr id="ben_9781319297145_ufpqIhwTix">
<td class="left" id="ben_9781319297145_YaMvo7YZEs"><i class="semantic-i" id="ben_9781319297145_XPaxXbgG3q">trp-1</i></td>
<td class="center" id="ben_9781319297145_00uZYe0bwo">−</td>
<td class="center" id="ben_9781319297145_opmIHukT87">−</td>
<td class="center" id="ben_9781319297145_FRvppfEs37">−</td>
<td class="center" id="ben_9781319297145_Appr7xgm6J">−</td>
<td class="center" id="ben_9781319297145_Hn3QD832p2">+</td>
</tr>
<tr id="ben_9781319297145_qW8wkI5Eaj">
<td class="left" id="ben_9781319297145_a8IYnyzuaJ"><i class="semantic-i" id="ben_9781319297145_OxmY0SoelQ">trp-2</i></td>
<td class="center" id="ben_9781319297145_LcCAgeRsGY">−</td>
<td class="center" id="ben_9781319297145_2bMn88fE2E">−</td>
<td class="center" id="ben_9781319297145_88rgOs9J62">+</td>
<td class="center" id="ben_9781319297145_UqTT7y6HiJ">+</td>
<td class="center" id="ben_9781319297145_hGoLhclzpr">+</td>
</tr>
<tr id="ben_9781319297145_djLhidkVmn">
<td class="left" id="ben_9781319297145_EIWeEcSsPa"><i class="semantic-i" id="ben_9781319297145_C7WTX1kfyc">trp-3</i></td>
<td class="center" id="ben_9781319297145_HaTfoaebau">−</td>
<td class="center" id="ben_9781319297145_NKVuE9kKHF">−</td>
<td class="center" id="ben_9781319297145_UsjPpFXsTR">−</td>
<td class="center" id="ben_9781319297145_sEWJg4ogp3">+</td>
<td class="center" id="ben_9781319297145_xgRVWrM1Po">+</td>
</tr>
<tr id="ben_9781319297145_ga7tSOqEqi">
<td class="left" id="ben_9781319297145_NmRTBInLNa"><i class="semantic-i" id="ben_9781319297145_kEVdHdaYsx">trp-4</i></td>
<td class="center" id="ben_9781319297145_tvc5aS73r1">−</td>
<td class="center" id="ben_9781319297145_djqGQLZyTN">−</td>
<td class="center" id="ben_9781319297145_EAOeDcPume">+</td>
<td class="center" id="ben_9781319297145_e2LtpRJmji">+</td>
<td class="center" id="ben_9781319297145_bUTlxANOXw">+</td>
</tr>
<tr id="ben_9781319297145_OcEfsshy2y">
<td class="left" id="ben_9781319297145_DcgMnK8xQz"><i class="semantic-i" id="ben_9781319297145_BcObbkh2hC">trp-6</i></td>
<td class="center" id="ben_9781319297145_YA6q0BY6Aw">−</td>
<td class="center" id="ben_9781319297145_9LTlfydGym">−</td>
<td class="center" id="ben_9781319297145_2QxXubX3DI">−</td>
<td class="center" id="ben_9781319297145_LPQZ9DGqml">−</td>
<td class="center" id="ben_9781319297145_mCxUZpT3vc">+</td>
</tr>
<tr id="ben_9781319297145_Ga4vaICJwp">
<td class="left" id="ben_9781319297145_ev2rlUvtLc"><i class="semantic-i" id="ben_9781319297145_snUMz0SdxE">trp-7</i></td>
<td class="center" id="ben_9781319297145_Ru70CalVp0">−</td>
<td class="center" id="ben_9781319297145_AxuwHr9F9F">−</td>
<td class="center" id="ben_9781319297145_uZRTkSQRvK">−</td>
<td class="center" id="ben_9781319297145_qYLr7jXCpK">−</td>
<td class="center" id="ben_9781319297145_99ElbvtXFI">+</td>
</tr>
<tr id="ben_9781319297145_qNEsJscOgj">
<td class="left" id="ben_9781319297145_U30fablCZX"><i class="semantic-i" id="ben_9781319297145_37QY5VV5ho">trp-8</i></td>
<td class="center" id="ben_9781319297145_ZsLmTcUSif">−</td>
<td class="center" id="ben_9781319297145_HJVFqFJYLA">+</td>
<td class="center" id="ben_9781319297145_JryheTwgXo">+</td>
<td class="center" id="ben_9781319297145_7G7rU1SdWx">+</td>
<td class="center" id="ben_9781319297145_R3UkQULK8Z">+</td>
</tr>
<tr id="ben_9781319297145_LwUhe8u3IA">
<td class="left" id="ben_9781319297145_feutHAb3lY"><i class="semantic-i" id="ben_9781319297145_n6CNig6O1T">trp-9</i></td>
<td class="center" id="ben_9781319297145_HmHxdamqNm">−</td>
<td class="center" id="ben_9781319297145_7o4WRd80cQ">−</td>
<td class="center" id="ben_9781319297145_ihZKcfuGyy">−</td>
<td class="center" id="ben_9781319297145_BfCost6xQ7">−</td>
<td class="center" id="ben_9781319297145_NlQyqzBgwE">+</td>
</tr>
<tr id="ben_9781319297145_HFcKa0XxVy">
<td class="left" id="ben_9781319297145_gfrPkslf3Y"><i class="semantic-i" id="ben_9781319297145_HbKECx10Uc">trp-10</i></td>
<td class="center" id="ben_9781319297145_dNKurvDrO1">−</td>
<td class="center" id="ben_9781319297145_69bSq8uBNx">−</td>
<td class="center" id="ben_9781319297145_NVM7x5v7Id">−</td>
<td class="center" id="ben_9781319297145_ywcjU24wYp">−</td>
<td class="center" id="ben_9781319297145_ot1Bs8AsO4">+</td>
</tr>
<tr id="ben_9781319297145_CZMWYRBcwV">
<td class="left" id="ben_9781319297145_A6ja39wsxX"><i class="semantic-i" id="ben_9781319297145_DxdYIUuKfZ">trp-11</i></td>
<td class="center" id="ben_9781319297145_5CTdb8kQUD">−</td>
<td class="center" id="ben_9781319297145_1rACoSJr8S">−</td>
<td class="center" id="ben_9781319297145_bIuq0EmnNE">−</td>
<td class="center" id="ben_9781319297145_Xqx7qxNFyu">−</td>
<td class="center" id="ben_9781319297145_pf7uwMxaap">+</td>
</tr>
</table>
<ul class="ul-no-mark" id="ben_9781319297145_KCbXnWI2N6">
<li class="question noindent" epub:type="question" id="ben_9781319297145_mwCQgbu2Mq">Give the order of indole glycerol phosphate, indole, anthranilic acid, and tryptophan in a biochemical pathway leading to the synthesis of tryptophan. Indicate which step in the pathway is affected by each of the mutations.</li>
</ul></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_FDse3vaAuN">Compounds I, II, and III are in the following biochemical pathway:
<figure class="figure lm_img_lightbox unnum c5 center" id="ben_9781319297145_GLNXtUO9j3">
<img alt="An illustration shows a biochemical pathway." aria-describedby="ben_9781319297145_R4YkkHKwtr" class="figure" id="ben_9781319297145_pks2HscRNU" src="../images/piercegenetics7e_15_un19_21680.png"/>
</figure>
<aside class="hidden" id="ben_9781319297145_R4YkkHKwtr" title="hidden">
<p class="noindent" id="ben_9781319297145_mH8zZajfXV">Pointing left to right the precursor is followed by an arrow labeled enzyme A, pointing to compound 1. An arrow angled downward from compound 1 is labeled enzyme B and points to compound 2. An arrow pointing right from compound 2 is labeled enzyme C and points to compound 3.</p>
</aside>
<ul class="ul-no-mark" id="ben_9781319297145_WUiiAVL07a">
<li class="question noindent" epub:type="question" id="ben_9781319297145_TSm9vbn2dl">Mutation <i class="semantic-i" id="ben_9781319297145_JRfsghMsC7">a</i> inactivates enzyme A, mutation <i class="semantic-i" id="ben_9781319297145_IxuryxmfjY">b</i> inactivates enzyme B, and mutation <i class="semantic-i" id="ben_9781319297145_vkZT84VyEn">c</i> inactivates enzyme C. Mutants, each having one of these defects, were tested on a minimal medium to which compound I, II, or III was added. Fill in the results expected of these tests by placing a plus sign (+) for growth or a minus sign (−) for no growth in the following table.</li>
</ul>
</li>
</ol>
<table class="table sectioned c3 main-flow" id="ben_9781319297145_nQBbMEeqBT">
<tr id="ben_9781319297145_JTXz2VXuby">
<th id="ben_9781319297145_pHjOqZrWTM"/>
<th class="center rule-b" colspan="3" id="ben_9781319297145_WNnOjrvTft">Minimal medium to which is added</th>
</tr>
<tr id="ben_9781319297145_SveZPcW0qN">
<th class="center" id="ben_9781319297145_G0XFyg6nlm">Strain with mutation</th>
<th class="center" id="ben_9781319297145_MR7pxv5JQa">Compound I</th>
<th class="center" id="ben_9781319297145_ZEOhfu3UyN">Compound II</th>
<th class="center" id="ben_9781319297145_C15GGvqiQD">Compound III</th>
</tr>
<tr id="ben_9781319297145_VI8tgAYp2U">
<td class="center" id="ben_9781319297145_GNKQnBMf0D"><i class="semantic-i" id="ben_9781319297145_NMo7jkl0iB">a</i></td>
<td class="center" id="ben_9781319297145_FnsMPR6VAe"/>
<td class="center" id="ben_9781319297145_5dreGpRPTF"/>
<td class="center" id="ben_9781319297145_jKRMqIUAJv"/>
</tr>
<tr id="ben_9781319297145_OxG0OTUxB5">
<td class="center" id="ben_9781319297145_5qel89UJ0t"><i class="semantic-i" id="ben_9781319297145_36HdSu5gVG">b</i></td>
<td class="center" id="ben_9781319297145_x5MFZ7710n"/>
<td class="center" id="ben_9781319297145_5UNnas66eR"/>
<td class="center" id="ben_9781319297145_nKaP2iq2HU"/>
</tr>
<tr id="ben_9781319297145_ndbu8ze9VA">
<td class="center" id="ben_9781319297145_BtjcYJSTDZ"><i class="semantic-i" id="ben_9781319297145_XzCETmvwch">c</i></td>
<td class="center" id="ben_9781319297145_gETFzsiSPa"/>
<td class="center" id="ben_9781319297145_OxKdPt1xrT"/>
<td class="center" id="ben_9781319297145_Z7Ziwob7bm"/>
</tr>
</table>
</section>
<section class="subsect1" id="ben_9781319297145_EhxeTxadc5">
<header id="ben_9781319297145_0zE2K0oYoZ"><h4 class="level1" id="ben_9781319297145_UxFSSJebJL">Section 15.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_QLh367z6US" start="18">
<li class="question noindent" epub:type="question" id="ben_9781319297145_ToUVsZ2w75">A geneticist conducts the experiment outlined in <a class="crossref" href="pie_9781319216801_ch15_03.xhtml#ben_9781319297145_IxSrt0fh33" id="ben_9781319297145_zNiM1HceVJ"><strong class="important" id="ben_9781319297145_Sy31PPSbwd">Figure 15.8</strong></a>, but this time she combines guanine nucleotides (instead of uracil) with polynucleotide phosphorylase. Radioactively labeled protein should appear in which tube?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_1SD6G6cjZt">For the experiment outlined in <a class="crossref" href="pie_9781319216801_ch15_03.xhtml#ben_9781319297145_IxSrt0fh33" id="ben_9781319297145_giEeLD25BZ"><strong class="important" id="ben_9781319297145_vVKKAUUtGd">Figure 15.8</strong></a>, could Nirenberg and Matthaei have substituted RNA polymerase instead of polynucleotide phosphorylase without otherwise modifying the experiment? Why or why not?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_GrAtEgJMFv"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_iSe1nCmtYo" id="ben_9781319297145_4sO229upPM">*</a>Assume that the number of different types of bases in RNA is four. What would be the minimum codon size (number of nucleotides) required to specify all amino acids if the number of different types of amino acids in proteins were (a) 2, (b) 8, (c) 17, (d) 45, (e) 75?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_mn97iFIt5l"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_HApuILEIH7" id="ben_9781319297145_LjdmmpiK95">*</a>How many codons would be possible in a triplet code if only three bases (A, C, and U) were used?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_tQZGuCGhh0"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_JjUcki1q25" id="ben_9781319297145_Z5dtqTS2Ly">*</a>Referring to the genetic code presented in <a class="crossref" href="pie_9781319216801_ch15_03.xhtml#ben_9781319297145_mOyYzb6fs5" id="ben_9781319297145_7QgUjlP2gd"><strong class="important" id="ben_9781319297145_rkPkS5X2cg">Figure 15.10</strong></a>, give the amino acids specified by the following bacterial mRNA sequences.
<ol class="ol-alpha-lc" id="ben_9781319297145_z1LFWfFjv2">
<li class="question noindent" epub:type="question" id="ben_9781319297145_7PzbxdaFWI"><span class="keep" id="ben_9781319297145_mdAE8fPtaU">5<sup class="semantic-sup" id="ben_9781319297145_vpq5zGEayD">′</sup>−AUGUUUAAAUUUAAAUUUUGA−3<sup class="semantic-sup" id="ben_9781319297145_g57NGckemf">′</sup></span></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_vSF3tV0H6g"><span class="keep" id="ben_9781319297145_0MJa7hZ4br">5<sup class="semantic-sup" id="ben_9781319297145_8zGT2QGmxv">′</sup>−AGGGAAAUCAGAUGUAUAUAUAUAUAUGA−3<sup class="semantic-sup" id="ben_9781319297145_ubGuZcjWbd">′</sup></span></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_fxERd3WwgY"><span class="keep" id="ben_9781319297145_NQDvHvMmBc">5<sup class="semantic-sup" id="ben_9781319297145_PdJalpFOKv">′</sup>−UUUGGAUUGAGUGAAACGAUGGAUGAAAGAUUUCUCGCUUGA−3<sup class="semantic-sup" id="ben_9781319297145_xDsyLbvpfz">′</sup></span></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_uJG8ie8Kn4"><span class="keep" id="ben_9781319297145_0wUzYBn36o">5<sup class="semantic-sup" id="ben_9781319297145_XImk0KXEk5">′</sup>−GUACUAAGGAGGUUGUAUGGGUUAGGGGACAUCAUUUUGA−3<sup class="semantic-sup" id="ben_9781319297145_zXHCiF7bsH">′</sup></span></li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_Rv0g4BitaJ">A nontemplate strand of bacterial DNA has the following base sequence. What amino acid sequence will be encoded by this sequence?
<div aria-label="five super prime postfix minus ATGATACTAAGGCCC negative three super prime" class="informalequation" id="ben_9781319297145_o1SqblXVH7" role="math" tabindex="0"><m:math display="block"><m:semantics><m:mrow><m:msup><m:mn>5</m:mn><m:mo>′</m:mo></m:msup><m:mo lspace="0" rspace="0">−</m:mo><m:mtext>ATGATACTAAGGCCC</m:mtext><m:mo lspace="0" rspace="0">−</m:mo><m:msup><m:mn>3</m:mn><m:mo>′</m:mo></m:msup></m:mrow><m:annotation-xml encoding="application/xhtml+xml" name="alternative-representation"><img alt="five super prime postfix minus ATGATACTAAGGCCC negative three super prime" src="../images/MATH/pie_9781319216801_ch15_07EQ_0001.png"/></m:annotation-xml></m:semantics></m:math></div>
</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_Q30S4DpSRS">The following amino acid sequence is found in a tripeptide: Met-Trp-His. Give all possible nucleotide sequences on the mRNA, on the template strand of <span aria-label="464" epub:type="pagebreak" id="page464" role="doc-pagebreak" title="464"/>DNA, and on the nontemplate strand of DNA that can encode this tripeptide.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_4LbY72iFQZ">How many different mRNA sequences can encode a polypeptide chain with the amino acid sequence Met-Leu-Arg? (Be sure to include the stop codon.)</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_244ah8EQ0w"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_2mF1FvugGZ" id="ben_9781319297145_iL3Vqn5IL1">*</a>A series of tRNAs have the following anticodons. Consider the wobble rules listed in <a class="crossref" href="pie_9781319216801_ch15_03.xhtml#ben_9781319297145_MKVhGpd5eb" id="ben_9781319297145_LZcRfcquTI"><strong class="important" id="ben_9781319297145_DRFiElypbw">Table 15.2</strong></a>, and give all possible codons with which each tRNA can pair.
<ol class="ol-alpha-lc" id="ben_9781319297145_z8rU9TiQ7j">
<li class="question noindent" epub:type="question" id="ben_9781319297145_x9uoODsMvE">5<sup class="semantic-sup" id="ben_9781319297145_hJxSs0FlQF">′</sup>−GGC−3<sup class="semantic-sup" id="ben_9781319297145_pg6O2c7RiV">′</sup></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_uaW9L3XQ4B">5<sup class="semantic-sup" id="ben_9781319297145_tlt6Opb92J">′</sup>−AAG−3<sup class="semantic-sup" id="ben_9781319297145_Nxz2uRCfWb">′</sup></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_5b49KGnXGY">5<sup class="semantic-sup" id="ben_9781319297145_DoROLDmAAc">′</sup>−IAA−3<sup class="semantic-sup" id="ben_9781319297145_Bxo8Iwatfu">′</sup></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_1hts6SRUVI">5<sup class="semantic-sup" id="ben_9781319297145_BN3EGYglQq">′</sup>−UGG−3<sup class="semantic-sup" id="ben_9781319297145_5Cfk97mv1N">′</sup></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_6uiLxVvYht">5<sup class="semantic-sup" id="ben_9781319297145_m1erao4k2j">′</sup>−CAG−3<sup class="semantic-sup" id="ben_9781319297145_QocoZYCJTy">′</sup></li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_5VsHbH5RHk">A researcher creates random copolymers of three nucleotides each by mixing polynucleotide phosphorylase with guanine and adenine nucleotides in a ratio of 5 guanine nucleotides to 1 adenine. Give the different copolymers produced and their theoretical proportions.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_3RDXEDXnJl">Assume that the nucleotide at the 5<sup class="semantic-sup" id="ben_9781319297145_DB3ixhRtm8">′</sup> end of the first tRNA’s anticodon (the tRNA on the left) in <a class="crossref" href="pie_9781319216801_ch15_03.xhtml#ben_9781319297145_WwWKwvBYYm" id="ben_9781319297145_TlEjX086Q2"><strong class="important" id="ben_9781319297145_SNdiPylPkW">Figure 15.11</strong></a> was mutated from G to U. Give all codons with which the new, mutated anticodon could pair.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_AOz8v4sKKu">Which of the following amino acid changes could result from a mutation that changed a single base? For each change that could result from the alteration of a single base, determine which position of the codon (first, second, or third nucleotide) in the mRNA must be altered for the change to result.
<ol class="ol-alpha-lc" id="ben_9781319297145_qc581hNUzd">
<li class="question noindent" epub:type="question" id="ben_9781319297145_4q7g2pYk2y">Leu → Gln</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_wBIZ7Em6nt">Phe → Ser</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_8XWVcghFR8">Phe → Ile</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_l0QHrKhSGF">Pro → Ala</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_FHiMyo3FAW">Asn → Lys</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_vg7FEH4LEl">Ile → Asn</li>
</ol></li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_IT3uM5lB8X">
<header id="ben_9781319297145_X30hn1fKXn"><h4 class="level1" id="ben_9781319297145_NcEucEsLCk">Section 15.3</h4></header>
<ol class="numbered-list" id="ben_9781319297145_f5OUxmdnz2" start="30">
<li class="question noindent" epub:type="question" id="ben_9781319297145_D26dz1QpRd"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_V0DL5ATGIW" id="ben_9781319297145_1UoQ85O8RI">*</a>Arrange the following components of translation in the approximate order in which they would appear or be used in prokaryotic protein synthesis:
<ul class="ul-no-mark" id="ben_9781319297145_cayohrOFkB">
<li class="question noindent" epub:type="question" id="ben_9781319297145_nrKuklF1vK">70S initiation complex</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_oDtYSVgym1">30S initiation complex</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_7F6rp33ivH">release factor 1</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_NKFPqaJt5m">elongation factor G</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_0ndGT9ga5W">initiation factor 3</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_KPTS3iVTFQ">elongation factor Tu</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_RW5nxdxd7i">fMet-tRNA<sub class="semantic-sub" id="ben_9781319297145_Lm2zAj1Z7P">i</sub><sup class="semantic-sup" id="ben_9781319297145_ntM9wxrnmI">fMet</sup></li>
</ul></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_PpoO5DSqIf">Examine the tRNA in <a class="crossref" href="pie_9781319216801_ch15_04.xhtml#ben_9781319297145_impxmJU0EJ" id="ben_9781319297145_cCCnKYmTRk"><strong class="important" id="ben_9781319297145_Qvlp3YJwqA">Figure 15.14</strong></a>. What do you think would be the potential effect of a mutation in the part of the tRNA gene that encodes (a) the acceptor stem; (b) the anticodon; (c) one of the red nucleotide positions?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_mKrZ3VyO4w">The following diagram illustrates a step in the process of translation. Identify the following elements on the diagram.
<figure class="figure lm_img_lightbox unnum c5 center" id="ben_9781319297145_1bRsdkrZY8">
<img alt="A diagram shows a step in the process of translation." aria-describedby="ben_9781319297145_uVzIt2LdUp" class="figure" id="ben_9781319297145_K85BsUEzlG" src="../images/piercegenetics7e_15_un01_258336.png"/>
</figure>
<aside class="hidden" id="ben_9781319297145_uVzIt2LdUp" title="hidden">
<p class="noindent" id="ben_9781319297145_08oUSfdtMj">The diagram starts with an m R N A strand with a ribosome and a t R N A attached.</p><p class="noindent" id="ben_9781319297145_7k8SqOep7J">A t R N A without an amino acid with U A C at its base, is on the left side of the ribosome. A t R N A with anticodon G G G sits on the m R N A at sequence C C C with amino acids f met and proline attached to it. The codon on the left of R N A sequence C C C is A U G and the codon on the right is A C G. An arrow is drawn pointing right from the ribosome. A red codon labeled U A G is present on the right end of the m R N A strand.</p>
</aside>
<ol class="ol-alpha-lc" id="ben_9781319297145_Ry2XCFbIyK">
<li class="question noindent" epub:type="question" id="ben_9781319297145_9NF9IbjKiM">5<sup class="semantic-sup" id="ben_9781319297145_gKmB9JngSf">′</sup> and 3<sup class="semantic-sup" id="ben_9781319297145_nVGK71G1RN">′</sup> ends of the mRNA</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_D5vBKTezJO">A, P, and E sites</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_43GU3HL0ns">Start codon</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_SvqTXNHuBh">Stop codon</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_5Rs5ILPlrQ">Amino and carboxyl ends of the newly synthesized polypeptide chain</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_4o7DKTOlh0">Approximate location of the next peptide bond that will be formed</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_PfdZvIebdw">Place on the ribosome where release factor 1 will bind</li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_Lkx2jMabLR"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_m1ertCtqEG" id="ben_9781319297145_r097X3YnID">*</a>Refer to the diagram in <a class="crossref" href="pie_9781319216801_ch15_07.xhtml#ben_9781319297145_mKrZ3VyO4w" id="ben_9781319297145_yWMa1qd3aA">Problem 32</a> to answer the following questions.
<ol class="ol-alpha-lc" id="ben_9781319297145_6dHuFkqETx">
<li class="question noindent" epub:type="question" id="ben_9781319297145_jd908pFGB1">What will be the anticodon of the next tRNA added to the A site of the ribosome?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_kq3axo7WBt">What will be the next amino acid added to the growing polypeptide chain?</li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_9GALkOSe2d"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_lUzhNTIGnc" id="ben_9781319297145_dT3KUVmmCc">*</a>A synthetic mRNA added to a cell-free protein-synthesizing system produces a peptide with the following amino acid sequence: Met-Pro-Ile-Ser-Ala. What would be the effect on translation if the following components were omitted from the cell-free protein-synthesizing system? What, if any, type of protein would be produced? Explain your reasoning.
<ol class="ol-alpha-lc" id="ben_9781319297145_k72IPgK7wQ">
<li class="question noindent" epub:type="question" id="ben_9781319297145_M3D0YccYfU">Initiation factor 3</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_61eXo0XSQc">Initiation factor 2</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_BlUZJBervE">Elongation factor Tu</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_DlhL0JQCmh">Elongation factor G</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_iYHhFSsFUp">Release factors RF-1, RF-2, and RF-3</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_TsQUO1IeRX">ATP</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_yk3aRlj2we">GTP</li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_KU68tddcTq">
<div class="group v5" id="ben_9781319297145_I97GlL4Wxz">
<img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_AclZjyv70T" role="presentation" src="../images/piercegenetics7e_01_PG_18e.png"/>
 For each of the following sequences, place a check mark in the appropriate space to indicate the process <i class="semantic-i" id="ben_9781319297145_80IgeyWi0b">most immediately</i> affected by deleting the sequence. Choose only one process for each sequence (i.e., one check mark per sequence). For help, review <a class="crossref" href="pie_9781319216801_ch12_01.xhtml#ben_9781319297145_l3DG8meyw8" id="ben_9781319297145_n5U1OYNWoF">Chapters 12</a> to <a class="crossref" href="pie_9781319216801_ch15_01.xhtml#ben_9781319297145_fX20GwRzso" id="ben_9781319297145_QW4wd78Gov">15</a>.
<table class="table compact c5 center" id="ben_9781319297145_hGMARi0q1m">
<tr id="ben_9781319297145_omwWM4SULU">
<th id="ben_9781319297145_k8iUCLvLCG"/>
<th class="left rule-b" colspan="4" id="ben_9781319297145_0Pt5tgTUJ5"><span aria-label="465" epub:type="pagebreak" id="page465" role="doc-pagebreak" title="465"/>Process most immediately affected by deletion</th>
</tr>
<tr id="ben_9781319297145_yWvCR40IkI">
<th class="left" id="ben_9781319297145_POv3LIYrxF">Sequence deleted</th>
<th class="left" id="ben_9781319297145_nOnUW9s036">Replication</th>
<th class="left" id="ben_9781319297145_LxKfWXdgD8">Transcription</th>
<th class="center" id="ben_9781319297145_lm1trLT0Tk">RNA processing</th>
<th class="left" id="ben_9781319297145_S1WEhj8bfi">Translation</th>
</tr>
<tr id="ben_9781319297145_bzfNxSEQHn">
<td class="left" id="ben_9781319297145_5hoYUAmt3K"><strong class="important" id="ben_9781319297145_P2GiNjbFxc">a. </strong><i class="semantic-i" id="ben_9781319297145_oBAVxlHNw8">ori</i> site</td>
<td class="left" id="ben_9781319297145_HDS6Oadxkh"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_xeH42IswzO"/></td>
<td class="left" id="ben_9781319297145_gyS4y3h319"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_t8xuDLKa4d"/></td>
<td class="left" id="ben_9781319297145_FdVQfJt5so"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_sKOhsIlo7k"/></td>
<td class="left" id="ben_9781319297145_tK6KoYhN1Q"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_yS2WIDcCpp"/></td>
</tr>
<tr id="ben_9781319297145_aLacgiUPCu">
<td class="left" id="ben_9781319297145_0WDjkvGK2Q"><strong class="important" id="ben_9781319297145_2gEbq9ir9o">b.</strong> 3<sup class="semantic-sup" id="ben_9781319297145_6iyiKh9u4F">′</sup> splice site consensus</td>
<td class="left" id="ben_9781319297145_D1L6pcPjbM"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_x1a8WtGzlH"/></td>
<td class="left" id="ben_9781319297145_A2gNYhXU8C"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_WMgWNB48lO"/></td>
<td class="left" id="ben_9781319297145_UyPWrEIZVQ"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_baIWFakxHI"/></td>
<td class="left" id="ben_9781319297145_OuK9qkkOVV"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_Z8N7mBNUWT"/></td>
</tr>
<tr id="ben_9781319297145_9xyR1lETQc">
<td class="left" id="ben_9781319297145_Q60dzZng5G"><strong class="important" id="ben_9781319297145_UuEArDXaaE">c.</strong> Poly(A) tail</td>
<td class="left" id="ben_9781319297145_X0bo9QvsIE"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_g0xiEsH97W"/></td>
<td class="left" id="ben_9781319297145_N6oPyety0X"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_Y3jLPqvbEj"/></td>
<td class="left" id="ben_9781319297145_3v710twVwz"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_vnDNqqcVpu"/></td>
<td class="left" id="ben_9781319297145_Xx2kfMgl3O"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_w54osSzWpE"/></td>
</tr>
<tr id="ben_9781319297145_h7C01a06VY">
<td class="left" id="ben_9781319297145_NamJV62nlN"><strong class="important" id="ben_9781319297145_NKshD0SOU8">d.</strong> Terminator</td>
<td class="left" id="ben_9781319297145_rP6kNpvCSE"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_mK0EAWjU2W"/></td>
<td class="left" id="ben_9781319297145_qMbbr6fUXB"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_SLLm7xDBw6"/></td>
<td class="left" id="ben_9781319297145_bZ4g1Ckngg"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_gymyifevtg"/></td>
<td class="left" id="ben_9781319297145_KafQmayd7D"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_ShYwl0hvJp"/></td>
</tr>
<tr id="ben_9781319297145_mrdgUUZNEs">
<td class="left" id="ben_9781319297145_TIIPVAkNtr"><strong class="important" id="ben_9781319297145_DGQdXz9pMR">e.</strong> Start codon</td>
<td class="left" id="ben_9781319297145_xjlDuSwyw2"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_Kl9ejK9Iak"/></td>
<td class="left" id="ben_9781319297145_f4BSlfbASV"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_kaAnvaWEVD"/></td>
<td class="left" id="ben_9781319297145_DmR0gS7btN"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_Z1O2b2h2RO"/></td>
<td class="left" id="ben_9781319297145_gwfaiakljJ"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_n4m7gtNac3"/></td>
</tr>
<tr id="ben_9781319297145_IzGFwSV8L2">
<td class="left" id="ben_9781319297145_sumHWHGghF"><strong class="important" id="ben_9781319297145_7lskZvfhli">f.</strong> −10 consensus</td>
<td class="left" id="ben_9781319297145_OGqoFgpad0"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_PLaQRthfK9"/></td>
<td class="left" id="ben_9781319297145_n6t7vXHWfB"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_ddn3NlDyBf"/></td>
<td class="left" id="ben_9781319297145_R6DRpWKc36"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_Nz7MuiNTsi"/></td>
<td class="left" id="ben_9781319297145_93ucmbYHC5"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_pid4RR3bh9"/></td>
</tr>
<tr id="ben_9781319297145_M4sJndGa85">
<td class="left" id="ben_9781319297145_8kFTGnb05N"><strong class="important" id="ben_9781319297145_xDayh4VCud">g.</strong> Shine–Dalgarno</td>
<td class="left" id="ben_9781319297145_PcbT5EalpI"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_5n96xEcUY3"/></td>
<td class="left" id="ben_9781319297145_fDG3bJuu2S"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_SDguQvJmoB"/></td>
<td class="left" id="ben_9781319297145_NpaWiK3DBc"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_rBe1yL5IhV"/></td>
<td class="left" id="ben_9781319297145_JgT6q1HeQB"><span aria-label="fill-in word" class="fill-in word" id="ben_9781319297145_vq6WQp2kk1"/></td>
</tr>
</table></div>
</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_grtp1RZPwE"><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_ZBE3r66E5R" role="presentation" src="../images/piercegenetics7e_03_pg74.png"/> MicroRNAs are small RNA molecules that bind to the 3<sup class="semantic-sup" id="ben_9781319297145_CpmzhB4RKI">′</sup> end of mRNA and suppress translation (see <a class="crossref" href="pie_9781319216801_ch14_06.xhtml#ben_9781319297145_TUZBFLs6AG" id="ben_9781319297145_jlXQfSm4F9">Section 14.5</a>). Some eukaryotic mRNAs have internal ribosome-binding sites downstream of the 5<sup class="semantic-sup" id="ben_9781319297145_BsiLbulD5j">′</sup> cap, where ribosomes normally bind. In one investigation, miRNAs did not suppress translation by ribosomes that had attached to internal ribosome-binding sites (R. S. Pillai et al. 2005. <i class="semantic-i" id="ben_9781319297145_TYO3YqEtHZ">Science</i> 309:1573–1576). What does this finding suggest about how miRNAs suppress translation?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_mIEoVedon9">Give the amino acid sequence of the protein encoded by the mRNA in <a class="crossref" href="pie_9781319216801_ch15_04.xhtml#ben_9781319297145_yJD9nmHRDv" id="ben_9781319297145_kCywPKGbYn"><strong class="important" id="ben_9781319297145_Q1m0oU7tro">Figure 15.21</strong></a>.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_NtWfntnuqx">
<header id="ben_9781319297145_QwPvzRZSNO"><h4 class="level1" id="ben_9781319297145_k34UJUWdzA">Section 15.4</h4></header>
<ol class="numbered-list" id="ben_9781319297145_GjxzWrfTJW" start="38">
<li class="question noindent" epub:type="question" id="ben_9781319297145_WMk17TMq17"><div class="group v5" id="ben_9781319297145_vPgcEjYB52"><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_7Kvpq6yP8I" role="presentation" src="../images/piercegenetics7e_01_PG_18e.png"/> (a) Label the following features on the following diagram. Review <a class="crossref" href="pie_9781319216801_ch13_01.xhtml#ben_9781319297145_KBBmwjHUS4" id="ben_9781319297145_bGIrr8iDnp">Chapter 13</a> for components associated with transcription. (b) Is this figure from a bacterial or a eukaryotic cell? Explain your reasoning.
<ol class="ol-alpha-lc" id="ben_9781319297145_H5M2FrDVvd">
<li class="question noindent" epub:type="question" id="ben_9781319297145_3engoMRvaA">DNA</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_VwRTvoGok5">mRNA</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_AUOgUCx3jz">5<sup class="semantic-sup" id="ben_9781319297145_3dUvfxT2Df">′</sup> and 3<sup class="semantic-sup" id="ben_9781319297145_Qn2n4LNs6Q">′</sup> ends of the DNA</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_kPaZcI0HVm">5<sup class="semantic-sup" id="ben_9781319297145_OoLb7hcWey">′</sup> and 3<sup class="semantic-sup" id="ben_9781319297145_5ekFPNr0LJ">′</sup> ends of the mRNA</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_oFw2PNCvT6">ribosomes</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_6LGQ02brPn">approximate location of promoter</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_9rO7kF44KZ">approximate location of terminator</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_QzwLxJriVT">direction of transcription</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_ehCH1T74em">start codon</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_bzLYaxqZhJ">Shine–Dalgarno sequence</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_j7ktP7PuTR">stop codon
<figure class="figure lm_img_lightbox unnum c5 center" id="ben_9781319297145_bs5wIroGF0">
<img alt="A diagram shows m R N A strand’s right end forming a curve and being attached to a double stranded D N A sequence." aria-describedby="ben_9781319297145_T1BMaGwJsu" class="figure" id="ben_9781319297145_7AqXoRo8bz" src="../images/piercegenetics7e_15_un02_258338.png"/>
</figure>
<aside class="hidden" id="ben_9781319297145_T1BMaGwJsu" title="hidden">
<p class="noindent" id="ben_9781319297145_EdKXLj4OPi">On the left, three ribosomes with growing polypeptide chains are attached to the m R N A strand. The m R N A sequence separates large and small subunits of ribosome located above and below the strand respectively, as it approaches the bubble in D N A strand. This is followed by dissociation of polypeptide chain towards the right end.</p>
</aside></li></ol></div></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_JjTQbjhWFy"><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_jhTTxJrTVB" role="presentation" src="../images/piercegenetics7e_03_pg74.png"/> <a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_UMcfn2owOz" id="ben_9781319297145_veOLWup2ME">*</a>Mutations that introduce stop codons cause a number of genetic diseases. For example, from 2% to 5% of the people who have cystic fibrosis possess a mutation that causes a premature stop codon in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). This premature stop codon produces a truncated form of CFTR that is nonfunctional and results in the symptoms of cystic fibrosis (see <a class="crossref" href="pie_9781319216801_ch05_02.xhtml#ben_9781319297145_5vUO4FdWzA" id="ben_9781319297145_m9Ssq9Ikbr">Section 5.1</a>). One possible way to treat people with genetic diseases caused by these types of mutations is to trick the ribosome into reading through the stop codon, inserting an amino acid in its place. Although the protein produced may have one altered amino acid, it is more likely to be at least partly functional than is the truncated protein produced when the ribosome stalls at the stop codon. Indeed, geneticists have conducted clinical trials of a drug called PTC124 on people with cystic fibrosis. This drug interferes with the ribosome’s ability to correctly read stop codons (C. Ainsworth. 2005. <i class="semantic-i" id="ben_9781319297145_Z9DuKWTqZB">Nature</i> 438:726–728). On the basis of what you know about the mechanism of nonsense-mediated mRNA decay (NMD), would you expect NMD to pose a problem for this type of treatment? Why or why not?
<figure class="figure lm_img_lightbox unnum c5 center" id="ben_9781319297145_rKsOn45Hug">
<img alt="A photo shows a patient with cystic fibrosis undergoing respiratory therapy." class="figure" id="ben_9781319297145_tPKALJZ13Y" src="../images/piercegenetics7e_15_un03_234762.png"/>
<figcaption id="ben_9781319297145_BHi4cWaUBA">
<p class="noindent" id="ben_9781319297145_byCKNbgEFV">Patient with cystic fibrosis undergoing respiratory therapy.</p>
</figcaption>
</figure>
</li>
</ol>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_EApuxJZDiA">
<header id="ben_9781319297145_xsXBAk2Yb1"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_tKGtEuMzn9">Challenge questions</h3></header>
<section class="subsect1" id="ben_9781319297145_3VVITARn62">
<header id="ben_9781319297145_w7bADjbAJ3"><h4 class="level1" id="ben_9781319297145_JS2e1ttwpD">Section 15.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_xZQJ7b6PiA" start="40">
<li class="question noindent" epub:type="question" id="ben_9781319297145_2frI4W9GqV">The redundancy of the genetic code means that some amino acids are specified by more than one codon. For example, the amino acid leucine is specified by six different codons. Within a genome, synonymous codons are not present in equal numbers; some synonymous codons appear much more frequently than others, and the preferred codons differ among species. For example, in one species, the codon UUA might be used most often to specify leucine, whereas in another species, the codon CUU might be used most often. Speculate on a reason for this bias in codon us and why the preferred codons are not the same in all organisms.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_SLpT0KshgZ">
<header id="ben_9781319297145_HVx357R221"><h4 class="level1" id="ben_9781319297145_MWSJA30UKF"><span aria-label="466" epub:type="pagebreak" id="page466" role="doc-pagebreak" title="466"/>Section 15.3</h4></header>
<ol class="numbered-list" id="ben_9781319297145_UnF4kl9wiW" start="41">
<li class="question noindent" epub:type="question" id="ben_9781319297145_jo8StHiXdw">
<div class="group v5" id="ben_9781319297145_EGdZIwsfSw">
<img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_k87bEUP3jj" role="presentation" src="../images/piercegenetics7e_01_PG_18e.png"/> In what ways are spliceosomes (see <a class="crossref" href="pie_9781319216801_ch14_01.xhtml#ben_9781319297145_Jj2BQS456c" id="ben_9781319297145_xUjGhYozQt">Chapter 14</a>) and ribosomes similar? In what ways are they different? Can you suggest some possible reasons for their similarities?
</div>
</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_lDgNAOJgVn"><a class="crossref" href="pie_9781319216801_BM_answer.xhtml#ben_9781319297145_pIBDHVkCAj" id="ben_9781319297145_stdlcLQxO9">*</a>Several experiments were conducted to obtain information about how the eukaryotic ribosome recognizes the AUG start codon. In one experiment, the gene that encodes methionine initiator tRNA (tRNA<sub class="semantic-sub" id="ben_9781319297145_rOetzkW6hk">i</sub><sup class="semantic-sup" id="ben_9781319297145_ItZZLgrUaq">Met</sup>) was located and changed; specifically, the nucleotides that specify the anticodon on tRNA<sub class="semantic-sub" id="ben_9781319297145_K9IvqDhy46">i</sub><sup class="semantic-sup" id="ben_9781319297145_HqlhC7YmNQ">Met</sup> were mutated so that the anticodon in the tRNA was 5<sup class="semantic-sup" id="ben_9781319297145_rczafz4Oav">′</sup>–CCA–3<sup class="semantic-sup" id="ben_9781319297145_TwXXYRGjDv">′</sup> instead of 5<sup class="semantic-sup" id="ben_9781319297145_DYCKdRHhXe">′</sup>–CAU–3<sup class="semantic-sup" id="ben_9781319297145_SEGTy7a7Pq">′</sup>. When this mutated gene was placed in a eukaryotic cell, protein synthesis took place, but the proteins produced were abnormal. Some of these proteins contained extra amino acids, and others contained fewer amino acids than normal.
<ol class="ol-alpha-lc" id="ben_9781319297145_82X8NK3YTk">
<li class="question noindent" epub:type="question" id="ben_9781319297145_0fjSN3aoxY">What do these results indicate about how the ribosome recognizes the starting point for translation in eukaryotic cells? Explain your reasoning.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_smrwdPpDZq">If the same experiment had been conducted on bacterial cells, what results would you expect?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_h83MWaA3x2">Explain why some of the proteins produced contained extra amino acids while others contained fewer amino acids than normal.</li>
</ol></li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_njYcNcUoG4">
<div class="group v5" id="ben_9781319297145_xlarxlb0vy">
<img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_V0y2DsL7vd" role="presentation" src="../images/piercegenetics7e_01_PG_18e.png"/> In bacteria, the process of translation affects the speed of transcription (see <a class="crossref" href="pie_9781319216801_ch13_01.xhtml#ben_9781319297145_KBBmwjHUS4" id="ben_9781319297145_2Gr4aJYOjA">Chapter 13</a>)—efficient binding and progression of ribosomes along the mRNA increase the speed of transcription, whereas the absence of ribosomes on the mRNA slows the movement of RNA polymerase along the DNA. Treatment with an antibiotic that inhibits translation slows the progression of RNA polymerase along the DNA. Likewise, if ribosomal proteins are mutated in a way that slows or inhibits translation, the process of transcription also slows. Furthermore, mutations in ribosomes that speed up the process of translation also accelerate transcription. Propose a mechanism for how the process of translation could affect the speed of transcription.
</div>
</li>
</ol>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_uBwutvxcOa">
<header id="ben_9781319297145_ya8zHXkw8U"><h3 class="title cap v5" epub:type="title" id="ben_9781319297145_0nt3CruGQo"><img alt="" aria-hidden="true" class="decorative size-large inline" id="ben_9781319297145_XWhuDT3E9I" role="presentation" src="../images/SpeechBub_People_01.png"/> Active Learning: Think-Pair-Share Questions</h3></header>
<section class="subsect1" id="ben_9781319297145_v9SUes7rXM">
<header id="ben_9781319297145_Z1gYaHI3sB"><h4 class="level1" id="ben_9781319297145_ArV0Ncsevn">Section 15.1</h4></header>
<ol class="numbered-list" id="ben_9781319297145_tfX0Zq48oJ">
<li class="question noindent" epub:type="question" id="ben_9781319297145_UDiEYvgTTw">Archibald Garrod was an English physician who first proposed that genes encode enzymes. Like the work of Gregor Mendel (see <a class="crossref" href="pie_9781319216801_ch03_01.xhtml#ben_9781319297145_lgF7rF7G1D" id="ben_9781319297145_LzM7HDOsHB">Chapter 3</a>), his discovery had little impact on his contemporaries and was not widely accepted until many years later. Why are important discoveries in science sometimes not accepted immediately? Why does it often take years before they are generally accepted by other scientists?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_AsvaTjEPyj">Based on what you have now learned about how genes code for proteins, do you think the one gene, one polypeptide hypothesis is correct today? Why or why not?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_c9eihwIRBR">Compare and contrast the structure and function of proteins and nucleic acids. How are they similar, and how are they different? How do their different structures contribute to their different functions?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_v8Uzbt3pSV">
<header id="ben_9781319297145_cb1mJ1HIlf"><h4 class="level1" id="ben_9781319297145_r1UaUcV3qK">Section 15.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_uwrqF17wyZ" start="4">
<li class="question noindent" epub:type="question" id="ben_9781319297145_QOwcGAHs9P">A triplet code with three nucleotides per codon is the most efficient way to encode the 20 different amino acids. Why would cells be expected to use the most efficient code? In other words, what might be the advantages of using an efficient code?</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_pA6WZ4Okfy">Some evidence suggests that synonymous codons are not really synonymous. Sometimes mutations that change a codon to a synonymous codon produce an effect on the phenotype, even though the amino acid sequence of the protein is the same. Propose some ways in which synonymous codons might have different phenotypic effects.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_8zzH1fkbgh">There are three termination codons (UAA, UAG, and UGA) but usually only one initiation codon (AUG) is used. Propose some possible reasons for why there are more termination codons than initiation codons.</li>
<li class="question noindent" epub:type="question" id="ben_9781319297145_tKJVYc4h3T">Exceptions to the universality of the genetic code were once thought to be rare, but more and more exceptions are being found. As mentioned in the text, one study found that a significant proportion of bacteria in the environment use nonuniversal codons. Can you think of any advantages for an organism using nonuniversal codons?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_42uaVu040b">
<header id="ben_9781319297145_NnRzqRPoL1"><h4 class="level1" id="ben_9781319297145_Q6LrWeqKxm">Section 15.3</h4></header>
<ol class="numbered-list" id="ben_9781319297145_z6RV4FEYm6" start="8">
<li class="question noindent" epub:type="question" id="ben_9781319297145_OPKF4GtK5H">Structural analysis of bacterial release factor 1 (RF-1) and release factor 2 (RF-2) reveals that these proteins are similar in size and shape to a tRNA molecule. This similarity has sometimes been called molecular mimicry. Why might RF-1 and RF-2 have evolved to mimic tRNAs?</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_Xg5CDyRDOh">
<header id="ben_9781319297145_DQ6ebg6v5k"><h4 class="level1" id="ben_9781319297145_MrCeMAVFWP">Section 15.4</h4></header>
<ol class="numbered-list" id="ben_9781319297145_lgeqYTAPS5" start="9">
<li class="question noindent" epub:type="question" id="ben_9781319297145_oAJF3yi64o">In humans, there may be three times as many proteins as genes. If each gene encodes a protein, how can there be more proteins than genes?</li>
</ol>
</section>
</section>
<section class="learning-resources v1" epub:type="learning-resources" id="ben_9781319297145_9xelu6erpC">
<header id="ben_9781319297145_cMhyvWbgPR"><h3 class="title cap v1" epub:type="title" id="ben_9781319297145_fRdzwMhwLN"><span aria-label="467" epub:type="pagebreak" id="page467" role="doc-pagebreak" title="467"/><span aria-label="468" epub:type="pagebreak" id="page468" role="doc-pagebreak" title="468"/><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_Rpa7gnCtws" role="presentation" src="../images/piercegenetics7e_01_PG_17.png"/> Active Learning: Concept Mapping Exercises</h3></header>
<section class="subsect1" id="ben_9781319297145_fJZQtbSKJH">
<header id="ben_9781319297145_WCRNISUfph"><h4 class="level1" id="ben_9781319297145_phfcknbJSI">Introduction</h4></header>
<ol class="numbered-list" id="ben_9781319297145_UikWc5sWGU">
<li class="question noindent" epub:type="question" id="ben_9781319297145_t6mDqP7XZX">Create a concept map that outlines the genetic cause of isolated congenital asplenia (ICA). Include at least the following terms in your concept map: spleen, ICA, immunity, infections, <i class="semantic-i" id="ben_9781319297145_3WDODx3m5F">RSPA</i> gene, RSPA protein, ribosome, protein synthesis, ribosomopathy.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_zJrBmeSuad">
<header id="ben_9781319297145_0x84oSucl5"><h4 class="level1" id="ben_9781319297145_QNkvexe5Te">Section 15.1</h4></header>
<ol class="numbered-list" id="ben_9781319297145_BFrAUkelRM" start="2">
<li class="question noindent" epub:type="question" id="ben_9781319297145_xcmlw5o80k">Draw a concept map that summarizes the relationship between genes and proteins, incorporating the following terms into your map: gene; protein, one gene, one enzyme hypothesis, one gene, one polypeptide hypothesis, amino acids, peptide bond, primary structure, secondary structure, tertiary structure, quaternary structure, domain.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_DrBApmYwWp">
<header id="ben_9781319297145_zmbwbVG7KD"><h4 class="level1" id="ben_9781319297145_dJU98d0yyI">Section 15.2</h4></header>
<ol class="numbered-list" id="ben_9781319297145_JFF8bJDrL8" start="3">
<li class="question noindent" epub:type="question" id="ben_9781319297145_ViY2MKAqKb">Create a concept map that outlines the characteristics of the genetic code.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_ZQYWHt722M">
<header id="ben_9781319297145_VZxOgthDV1"><h4 class="level1" id="ben_9781319297145_SOWbiuksWX">Section 15.3</h4></header>
<ol class="numbered-list" id="ben_9781319297145_caoXisgj0h" start="4">
<li class="question noindent" epub:type="question" id="ben_9781319297145_caYzNwlKmS">Draw a concept map that reviews the major components involved in the four steps of bacterial translation and their functions.</li>
</ol>
</section>
<section class="subsect1" id="ben_9781319297145_3x5jTKuneM">
<header id="ben_9781319297145_JeGE9kba5n"><h4 class="level1" id="ben_9781319297145_MycdohqXXm">Section 15.4</h4></header>
<ol class="numbered-list" id="ben_9781319297145_J9GDueFFE8" start="5">
<li class="question noindent" epub:type="question" id="ben_9781319297145_xtEO8y4UZ2">Summarize mRNA surveillance mechanisms with a concept map that includes the following terms: translation, mRNA, mRNA surveillance, nonsense mutations, nonsense-mediated mRNA decay, stalled ribosome, transfer-messenger RNA, alternative ribosome-rescue factors, nonstop decay, no-go decay.</li>
</ol>
</section>
<aside aria-label="learning-resources" class="learning-resources c3 main-flow v1" epub:type="learning-resources" id="ben_9781319297145_UKfyF5Vruc" title="learning-resources">
<p class="noindent" id="ben_9781319297145_U7ZsC97CKu"><img alt="" aria-hidden="true" class="decorative size-med inline" id="ben_9781319297145_f65wqTtYFq" role="presentation" src="../images/piercegenetics7e_03_pg80.png"/> Self-study tools that will help you practice what you’ve learned and reinforce this chapter’s concepts are available online. Go to <a class="external" href="http://www.saplinglearning.com" id="ben_9781319297145_M5xu1yuIxZ">www.saplinglearning.com</a>.</p>
</aside>
</section>
</section>
</body>
</html>